Superworth

Palvella Therapeutics EPS PVLA

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$4.82
Latest quarter, Q2 FY26
−$1.52
Fiscal year 2025
−$3.70

Palvella Therapeutics' earnings per share was −$4.82 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.52.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.70n/a
FY2024−$8.89n/a
FY2021−$55.20n/a
FY2020−$54.40n/a
FY2019−$44.80n/a
FY2018−$40.00n/a
FY2017−$32.80n/a
FY2016−$42.40n/a
FY2015−$33.60n/a
FY2014−$24.80n/a
FY2014−$55.20n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$1.52n/a−$4.82
Q1 FY26−$1.20n/a−$4.16
Q4 FY25−$1.07n/a−$3.70
Q3 FY25−$1.03n/a−$3.57
Q2 FY25−$0.86n/a−$6.48
Q1 FY25−$0.74n/a−$8.09
Q4 FY24−$0.94n/a−$8.89
Q3 FY24−$3.94n/an/a
Q2 FY24−$2.47−168%n/a
Q1 FY24−$1.54n/an/a
Q3 FY23−$8.70n/an/a
Q2 FY23$3.62n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Palvella Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
PVLAPalvella Therapeutics−$4.82
ANIPANI Pharmaceuticals$4.70
PAHCPhibro Animal Health$2.44+107% a year
HRMYHarmony Biosciences$3.09−0% a year
ANABAnaptysbio$4.57
PCRXPacira BioSciences$0.35
PBHPrestige Consumer Healthcare$3.57−16% a year
OMEROmeros$1.52
NRIXNurix Therapeutics$2.31
AMPHAmphastar Pharmaceuticals$1.70−36% a year
OGNOrganon$0.77−71% a year
Peer median$2.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Palvella Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.